Table 3 Sequelae and long-term treatment failure among women with and without baseline Mycoplasma gentalium (MG) genital tract infection
OutcomeCervical and/or endometrial Mg+ n (%) n = 88Cervical and/or endometrial Mg− n (%) n = 498Adjusted RR* (95% CI)Endometrial Mg+ n (%) n = 50Endometrial Mg− n (%) n = 561Adjusted RR* (95% CI)
Recurrent pelvic inflammatory disease24 (28.2)98 (20.8)1.6 (0.8 to 3.1)15 (30.6)111 (20.8)1.8 (0.8, 3.8)
Infertility15 (17.4)95 (19.4)1.4 (0.6 to 2.9)11 (22.0)104 (18.9)1.1 (0.7 to 4.0)
Chronic pelvic pain37 (43.5)198 (41.4)1.6 (0.9 to 2.9)21 (42.0)226 (42.1)1.3 (0.6 to 2.7)
Pregnancy53 (61.6)278 (56.9)0.8 (0.4 to 1.5)29 (58.0)317 (57.6)0.7 (0.3 to 1.4)
Live birth34 (50.7)207 (48.5)0.7 (0.3 to 1.3)19 (46.3)236 (49.3)0.6 (0.3 to 1.3)
  • *All models are adjusted for age, race, Neisseria gonorrhoeae and Chlamydia trachomatis. Infertility, pregnancy and live birth models are additionally adjusted for self reported infertility at baseline.